Analysis Group Announces Staff Promotions, Welcomes New Affiliates
Analysis Group, February 13, 2012
Analysis Group announces the promotions of a new managing principal, four new vice presidents, and 10 new managers, effective immediately. The firm also welcomes four new affiliates: Jonathan F. Foster, Frank R. Lichtenberg, John J. Richard, and Steven M. Shugan. “We are incredibly pleased to recognize the outstanding contributions and commitment to client service shown by our consultants,” said President and CEO Martha S. Samuelson. “They bring a diverse set of skills and experiences to all our practice areas, as do our new affiliates.”
Jonathan F. Foster – Mr. Foster is the founder and managing director of Current Capital, a private equity and portfolio company management firm. He is an authority in corporate finance, governance, private equity, and merger and acquisition litigation matters. Mr. Foster is highly experienced in board issues, initial public offerings, debt financing, restructurings, corporate acquisitions and sales, and private equity transactions. He spent more than 10 years in mergers and acquisitions at Lazard, where he was ultimately a managing director; he was also a managing director at Wachovia Securities and Bear Stearns.
Frank R. Lichtenberg, Ph.D. – Dr. Lichtenberg is an expert on industrial organization, applied microeconomics, and econometrics. He is a professor at Columbia University’s Graduate School of Business. His research focuses on how the introduction of new technologies arising from R&D investment affects the productivity of companies, industries, and nations. He is a research associate of the National Bureau of Economic Research and has served as an expert for the Federal Trade Commission, the Department of Justice (DOJ), the Internal Revenue Service, and state attorneys general. He has testified before Congress and has worked for several government agencies, including the DOJ, the Congressional Budget Office, and the Census Bureau.
John J. Richard – Mr. Richard is a fund manager and securities consultant with more than 15 years of experience in institutional money management. He was a founder of Taurus Horizon Fund, where he was a managing partner and fund manager for the strategy. Previously, he served at State Street Global Advisors as a senior fixed income portfolio manager. The assets under his management exceeded $10 billion dollars. Mr. Richard’s investment expertise spans a variety of security types, including unsecured corporate credit and securitized structures (such as ABS, MBS, CMBS, and CDO). Over his career, Mr. Richard has also taken an active role in trading securities and performing due-diligence credit work on the underlying collateral.
Steven M. Shugan, Ph.D. – Dr. Shugan is the McKethan-Matherly Eminent Scholar Chair at the University of Florida. He is an expert in marketing models, multivariate statistics, quantitative methods, and advanced marketing management. His current research focuses on model validation, bundling, seasonality, normative methods for modeling competition, models of selling and product policy, advance selling, entertainment marketing, and markets for evaluative information. Dr. Shugan has been published extensively and has made more than 100 professional presentations in more than 22 countries. He is a fellow of the Institute for Operations Research and Management Sciences and an inaugural fellow of the Society for Marketing Science.
New Managing Principal
Anita Chawla, Ph.D.– Dr. Chawla has more than 20 years of experience as a health economist, using analyses to support the business objectives of life sciences companies. As a member of our Menlo Park office, Dr. Chawla has played a lead role in developing an early phase economic-modeling capability for pharmaceuticals—an approach that connects strategic planning with health economics. She has assessed the value of a range of therapies to inform health care decision makers. An expert in all phases of drug development, she has designed economic and outcomes research strategies for product development and commercialization objectives. Dr. Chawla has also conducted research and published on a range of health economics issues, including treatment patterns and outcomes, economic burden of various illnesses, cost-effectiveness analysis in clinical trials, drug spending trends, and performance measures for prescription drug management.
New Vice Presidents
In our Boston office, Mark J. Lewis, Ph.D., conducts analyses using large-scale data sets and has supported expert testimony in a number of health care, antitrust, intellectual-property, and class action matters. Crystal Pike, also in Boston, has managed cases involving analysis of marketing practices in the pharmaceutical industry; economic analysis of physician-payment structures under capitation; and pricing analyses for large multinational corporations across numerous industries. Dov Rothman, Ph.D., also in Boston, is an economist with a range of expertise in applied microeconomics, econometrics, health economics, industrial organization, labor economics, and statistics. Justin F. Works, in our Menlo Park office, specializes in the biotechnology and pharmaceuticals industries, conducting competitive assessments of and developing product pricing and rebating strategies for high-profile health-related products in a variety of therapeutic areas.
New Managers and Senior Economists
In Boston, Ka Ming Cheng, Sara Eapen, and Lauren Hunt. In Los Angeles, Eric B. Nguyen. In Menlo Park, Stephan McBride, Ph.D. In San Francisco, Elizabeth Stone, Ph.D. In Montreal, Marie-Helene Lafeuille, Francois Laliberte, Laura O’Laughlin, and Joshua White. In late 2011, Analysis Group also welcomed Edi Grgeta Ph.D., to its Chicago office and Anna Meyendorff, Ph.D., to its Boston office.
Reposted from Analysis Group Article.